Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|173|1|17-18

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.173, Iss.1, 2015-07, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bullous Pemphigoid in an HB Virus Carrier: Interaction between Corticosteroids and HB Virus

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 3, 1997-03 ,pp. : 179-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 320-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 415-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate‐to‐severe bullous pemphigoid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 302-304

John Wiley & Sons Inc

Access to resources Recommend Favorite